Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Pharmaceuticals ETF (NY:XPH)

66.64 +0.55 (+0.83%)

Streaming Delayed Price Updated: 1:47 PM EDT, Sep 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	241,631
Open	65.76
Bid (Size)	66.54 (200)
Ask (Size)	66.62 (100)
Prev. Close	66.09
Today's Range	65.55 - 66.99
52wk Range	46.90 - 74.34
Shares Outstanding	36,002
Dividend Yield	0.35%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

IXJ vs XPH: Global Healthcare ETF or Pharma Focus? ↗

September 11, 2026

XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.

Via The Motley Fool

Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH ↗

September 10, 2026

Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.

Via The Motley Fool

Performance

YTD	+20.7%	+20.7%
1 Month	-5.9%	-5.9%
3 Month	+0.3%	+0.3%
6 Month	+29.8%	+29.8%
1 Year	+40.2%	+40.2%

More News

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? ↗

September 10, 2026

Via The Motley Fool

Why Did AQST Stock Plunge 40% In Pre-Market Today? ↗

January 09, 2026

Via Stocktwits

XPH vs PJP: Which Pharma ETF Offers Better Value ↗

August 17, 2026

Via The Motley Fool

Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH ↗

August 12, 2026

Via The Motley Fool

Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH? ↗

July 16, 2026

Via The Motley Fool

Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH? ↗

July 08, 2026

Via The Motley Fool

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? ↗

July 08, 2026

Via The Motley Fool

State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? ↗

June 04, 2026

Via The Motley Fool

Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? ↗

June 04, 2026

Via The Motley Fool

ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts ↗

March 10, 2026

Via Stocktwits

Why Did CANF Stock Soar 40% In Pre-Market Today? ↗

March 04, 2026

Via Stocktwits

TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗

March 03, 2026

Via Stocktwits

FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗

February 18, 2026

Via Stocktwits

NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results ↗

February 10, 2026

Via Stocktwits

Why Did CRMD Stock Crash 28% Today? ↗

January 08, 2026

Via Stocktwits

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Via Benzinga

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

Via Benzinga

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

Via Benzinga

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

Via Investor's Business Daily

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗

September 08, 2025

Via Benzinga

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. ↗

August 22, 2025

Via Investor's Business Daily

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗

August 01, 2025

Via Benzinga

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

Via MarketMinute

Frequently Asked Questions

Is State Street SPDR S&P Pharmaceuticals ETF publicly traded?

Yes, State Street SPDR S&P Pharmaceuticals ETF is publicly traded.

What exchange does State Street SPDR S&P Pharmaceuticals ETF trade on?

State Street SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange

What is the ticker symbol for State Street SPDR S&P Pharmaceuticals ETF?

The ticker symbol for State Street SPDR S&P Pharmaceuticals ETF is XPH on the New York Stock Exchange

What is the current price of State Street SPDR S&P Pharmaceuticals ETF?

The current price of State Street SPDR S&P Pharmaceuticals ETF is 66.64

When was State Street SPDR S&P Pharmaceuticals ETF last traded?

The last trade of State Street SPDR S&P Pharmaceuticals ETF was at 09/28/26 01:47 PM ET

What is the market capitalization of State Street SPDR S&P Pharmaceuticals ETF?

The market capitalization of State Street SPDR S&P Pharmaceuticals ETF is 2.40M

How many shares of State Street SPDR S&P Pharmaceuticals ETF are outstanding?

State Street SPDR S&P Pharmaceuticals ETF has 2M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.